Purpose/Objective(s) To investigate the expression of Per1, Per2 and Per3 in head and neck squamous cell carcinoma(HNSCC); detect the relationship between Per1, Per2,Per3 gene expression level and clinical stages of HNSCC; explore the association of Per1, Per2,Per3 protein expression with clinical features, clinical stages and survival of HNSCC. Materials/Methods The 7 normal tissue samples and 20 HNSCC tissue were collected. QPCR method was used to detect the expression of Per1, Per2 ,Per3 genes in HNSCC tissue and normal tissues. Based on patient clinical stages, (I-II) was identified as early group,(III-IV) was identified as late group. Explore the gene expression of Per1, Per2,Per3 in early and late stages. In the same time, 60 HNSCC tissue and 20 normal tissue were collected. Immunohistochemistry was used, the product of multiplying by staining grading and staining cell percentage was used to determine Per1, Per2, Per3 protein expression. Results The expression of Per1, Per2,Per3 gene expression in HNSCC tissue was reduced compared with normal tissue (P<0.01). The patient of late stage, reduction levels of Per2 and Per3 genes was higher than early stage. According to immunohistochemistry, protein positive rate of Per1, Per2,Per3 genes in normal tissue was higher that of Per1, Per2,Per3 genes in HNSCC tissue (P<0.05). For the patient of HNSCC, OS in Per1 and Per3 negative groups in 1 year,2 years,3 years were 80.6%, 51.6% and 29%, respectively; positive groups in 1 year, 2 years and 3 years were 98.6%, 86.2% and 72.4%(P0.05). In Per1 and Per3 protein positive groups, PFS in 1 year, 2 years and 3 years were 96.6%, 69% and 55.2%, respectively; in negative groups, PFS in 1 year, 2 years and 3 years were 71%, 32.3% and 16.1%(P<0.05).PFS in Per2 positive group in 1 year, 2 years and 3 years were 96.3%, 77.8% and 59.2%, respectively; negative group in 1 year, 2 years and 3 years were 72.7%, 33.3% and 24.2% (P<0.05); RFS in Per1 and Per3 negative groups in 1 year, 2 years and 3 years were 77.4%, 45.2% and 35.5%, respectively; positive group in 1 year, 2 years and 3 years were 96.6%, 82.8% and 67.7% (P<0.05). RFS in Per2 protein negative group in 1 year, 2 years and 3 years were 81.8%, 48.4.% and 36.3%, respectively; positive group in 1 year, 2 years and 3 years were 96.3%, 81.5% and 66.7% (P<0.05). Conclusion Per1, Per2 and Per3 genes may play a critical role in the occurrence and development of HNSCC,compared with negative Per1 and Per3 protein expression, patients with positive Per1 and Per3 protein expression may have longer OS and show the trend of extended PFS and RFS.